The effect of norepinephrine versus dopamine in renal transplant recipients on postoperative graft function

References

• Ojo AO, Hanson JA, Meier-Kriesche H-U, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001;12(3):589–97. doi: 10.1681/ASN.V123589
   PubMed Web of Science ®Google Scholar
• Aulakh NK, Garg K, Bose A, et al. Influence of hemodynamics and intra-operative hydration on biochemical outcome of renal transplant recipients. J Anaesthesiol Clin Pharmacol. 2015;31(2):174. doi: 10.4103/0970-9185.155144
   PubMedGoogle Scholar
• Sprung J, Kapural L, Bourke DL, et al. Anesthesia for kidney transplant surgery. Anesthesiol Clin N Am. 2000;18(4):919–51. doi: 10.1016/S0889-8537(05)70202-9
   PubMedGoogle Scholar
• De Gasperi A, Narcisi S, Mazza E, et al., editors. Perioperative fluid management in kidney transplantation: is volume overload still mandatory for graft function? Transplantation Proceedings; 2006: Elsevier.
   Google Scholar
• Choi JM, Jo J-Y, Baik J-W, et al. Risk factors and outcomes associated with a higher use of inotropes in kidney transplant recipients. Medicine. 2017;96(1):e5820. doi: 10.1097/MD.0000000000005820
   PubMed Web of Science ®Google Scholar
• Kee WDN, Lee SWY, Ng FF, et al. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. J Am Soc Anesthesiologists. 2015;122(4):736–45. doi: 10.1097/ALN.0000000000000601
   PubMed Web of Science ®Google Scholar
• Altaf F, Griesdale DE, Belanger L, et al. The differential effects of norepinephrine and dopamine on cerebrospinal fluid pressure and spinal cord perfusion pressure after acute human spinal cord injury. Spinal Cord. 2016;55(1):33–38. doi: 10.1038/sc.2016.79
   PubMed Web of Science ®Google Scholar
• Corradi F, Brusasco C, Paparo F, et al. Renal doppler resistive index as a marker of oxygen supply and demand mismatch in postoperative cardiac surgery patients. Biomed Res Int. 2015;2015:1–7. doi: 10.1155/2015/763940
   Web of Science ®Google Scholar
• Glavaš M, Gitlin-Domagalska A, Dębowski D, et al. Vasopressin and its analogues: from natural hormones to multitasking peptides. Int J Mol Sci. 2022;23(6):3068. doi: 10.3390/ijms23063068
   PubMed Web of Science ®Google Scholar
• Ciapetti M, Di Valvasone S, di Filippo A, et al. Low-dose dopamine in kidney transplantation. Transplantation proceedings; 2009. Elsevier.
   Google Scholar
• Russell JA. Vasopressor therapy in critically ill patients with shock. Intensive care Med. 2019;45(11):1503–17. doi: 10.1007/s00134-019-05801-z
   PubMed Web of Science ®Google Scholar
• Jan MY, Moe SM, Adebiyi O, et al. Vasopressin for post-kidney transplant hypotension. Kidney Int Rep. 2022;7(6):1364–76. doi: 10.1016/j.ekir.2022.03.035
   PubMed Web of Science ®Google Scholar
• Flancbaum L, Dick M, Choban PS, et al. Effects of low-dose dopamine on urine output in oliguric, critically ill, renal transplant patients. Clin Transplant. 1998;12(3):256–9.
   PubMed Web of Science ®Google Scholar
• Maraghi E, Rahimi Foroushani A, Younespour S, et al. Longitudinal assessment of serum creatinine levels on graft survival after renal transplantation. Joint Modeling Approach Nephrourol Mon. 2016 Jun 7;8(4). doi: 10.5812/numonthly.37666
   Google Scholar
• Grundmann R, Kindler J, Meider G, et al. Dopamine treatment of human cadaver kidney graft recipients: a prospectively randomized trial. Klinische Wochenschrift. 1982;60(4):193–197. doi: 10.1007/BF01715586
   PubMedGoogle Scholar
• Levy B, Perez P, Perny J, et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study*. Crit Care Med. 2011;39(3):450–5. doi: 10.1097/CCM.0b013e3181ffe0eb
   PubMed Web of Science ®Google Scholar
• Friedrich JO, Adhikari N, Herridge MS, et al. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann internal med. 2005;142(7):510–24. doi: 10.7326/0003-4819-142-7-200504050-00010
   PubMed Web of Science ®Google Scholar
• Bajpai P, Pandey A, Mittal A, et al. Open label study of intensive vasopressors therapy in critical care-survival benefits vs side effects. Sepsis. 2016;32:1–4. doi: 10.20530/IJTA_32_1-4
   Google Scholar